Saturday, February 06, 2021 2:34:38 PM
Another rumor going around is that Tryp Therapeutics, currently trading on the Canadian Securities exchange as TRYP, will proceed with a Herborium Group merger in order to access the U.S. OTCMarket.
Further evidence that may confirm this is that TRYP confirmed on Twitter that they’re looking to get an OTC ticker in 2021. Another reason is that former president of Herborium Group, Jim Gillian was appointed as Co-President for Tryp and Chief Scientific Officer, strengthening the merger rumor.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM